Intracerebral production of tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer disease and vascular dementia

Journal of Clinical Immunology

Volumn 19, Issue 4, 1999, Pages 223-230

  Tarkowski, Elisabeth ^a   Blennow, Kaj ^a   Wallin, Anders ^a   Tarkowski, Andrzej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Apoptosis; Dementia; Tau protein; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN BCL 2; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BRAIN LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MALE; MULTIINFARCT DEMENTIA; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

AGED; ALZHEIMER DISEASE; ANTIGENS, CD95; APOPTOSIS; BRAIN; DEMENTIA, VASCULAR; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; TAU PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032868874     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020568013953     Document Type: Article

References (44)

1. Iqbal K: Prevalence and neurobiology of Alzheimer disease: Some highlights. In Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. K Iqbal, DRC McLachlan, B Winblad, HM Wisniewski (eds). Chichester, Wiley-Interscience, 1991, pp 9-12
2. Rossor M: Disorders of psychic function. Dementia. In Disease of the Nervous System: Clinical Neurobiology, 2nd ed, AK Asbury, GM McKhann, WI McDonald (eds). Philadelphia, W. B. Saunders, 1992, pp 788-794
3. Banati RB, Beyreuter K: Alzheimer's disease. In Neuroglia, H Kellenman, BR Ransom (eds). New York, Oxford, Oxford University Press, 1995, pp 1027-1043
4. McGeer PL, Akiyama H, Itagaki S, McGeer EG: Immune system response in Alzheimer's disease. Can J Neurol Sci 16:516-527, 1989
5. McGeer PL, Itagaki S, Tago H, McGeer EG: Reactive microglia in patients with senile dementia of Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79:195-200, 1987
6. St. Pierre BA, Merill JF, Dopp JM: Effects of cytokines on the CNS cells: Glia. In Cytokines and the CNS, RM Ransohoff, EN Benveniste (eds). Boca Raton, FL, CRC Press, 1996, pp 151-168
7. Bauer J, Ganter U, Strauss S, Stadtmuller G, Frommberger U, Bauer H, Volk B, Berger M: The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. 45th Forum in Immunology. Res Immunol 143:650-657, 1992
8. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611-7615, 1989
9. Vandenabeele P, Fiers W: Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated "acute phase response" in the brain? Immunol Today 12:217-219, 1991
10. Goldgaber D, Harris HW, Hla T, Maciag T, Donnely RJ, Jacobsen JS, Vitek MP, Gajdusek DC: Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86:7606-7610, 1989
11. Brenneman DE, Schultzberg M, Bartfai T, Gozes I: Cytokine regulation of neuronal survival. J Neurochem 58:454-460, 1992
12. Hama T, Miyamoto M, Tsukui H, Nishio C, Hatanaka H: Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergie neurons from postnatal rats. Neurosci Lett 104:340-344, 1989
13. Frei K, Malipiero UV, Leist TP, Zinckernagel RM, Schwab ME, Fontana A: On the cellular source and function of interleukin-6 pruduced in the central nervous system in viral diseases. Eur J Immunol 19:689-694, 1989
14. Satoh T, Nakamura S, Taga T, Matsuda T, Hirano T, Kishimoto T, Kasiro Y: Induction or Neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol Cell Biol 8:3546-3549, 1988
15. Cheng B, Christakos S, Mattson MP: Tumor necrosis factors protect neurons against metabolic-excitatoxic insults and promote maintenance of calcium homeostasis. Neuron 12(1):139-153, 1994
16. Schwartz M, Solomon A, Lavie V, Ben RS, Belkin M, Coben A: Tumor necrosis factor facilitates regeneration of injured central nervous system axons. Brain Res 545:334-338, 1991
17. 2+ accumulation. Proc Natl Acad Sci USA 92:9328-9332, 1995
18. Gottfries C-G, Brane G, Cullberg B, Steen G: A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1:311-330, 1982
19. Roman GC, Tatemichi TK, Erkinjuntti T, et al.: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-ARIEN Internalional workshop. Neurology 43:250-260, 1993
20. Wallin A, Blennow K, Edman A, Mänsson JE: Decreased lumbar CSF levels of monoamine metabolites in vascular dementia. Int Psychogeriatr 8:425-436, 1996
21. Wallin A, Blennow K, Scheltens PH: Research criteria for clinical diagnosis of "pure" Alzheimers disease. Drugs Today 30:265-273, 1994
22. Landorp PM, Aarden LA, Calafat J, Zeijlemaker WP: A growth factor dependent B-cell hybridoma. Curr Top Microbiol Immunol 132:105-113, 1986
23. Aarden LA, de Groot ER, Shaap OL, Lansdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416, 1987
24. Helle M, Boeije L, Aarden LA: Functional discrimination between interleukin-6 and interleukin-1. Eur J Immunol 18:1535-1540, 1988
25. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A: Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393-1398, 1995
26. Blennow K, Wallin A, Ågren H, Spencer C, Siegfried J, Vanmechelen E: Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer's disease? Mol Chem Neuropathol 26:231-245, 1995
27. Biedler JL, Helson L, Spengler BA: Morphology and growth, tumorigenecity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652, 1973
28. Blennow K, Wallin A, Gottfries CG: Presence of parieto-temporal symptomatology distinguishes early- and late-onset Alzheimer disease. Int J Geriatr 6:149-156, 1991
29. Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotrop virus. Proc Natl Acad Sci USA 86:6348-6352, 1989
30. Right M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani AD, Domini S, Ricciardi-Castagnoli P: Monokine production by microglial cell clones. Eur J Immunol 19:1443-1448, 1989
31. McLaurin J, D'Souza S, Stewart J, Blain M, Beaudet A, Nalbantoglu J, Antel JP: Effect of tumor necrosis factor α and β on humans oligodendrocytes and neurons in culture. Int J Dev Neurosci 13:369-381, 1995
32. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A: Intrathecal release of pro- and antiinflammatory cytokines in stroke. Clin Exp Immunol 110:492-499, 1997
33. Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374:647-650, 1995
34. Itoh N, Nagata S: A novel protein domain required for apoptosis. J Biol Chem 268:10932-10937, 1993
35. Matsuyama T, Hata R, Yamamoto Y, Tagaya M, Akita H, Uno H, Wanaka A, Furuyama J, Sugita M: Localization of Fas antigen m-RNA induced in postischemic murine forebrain by the in situ hyhridization. Mol Brain Res 34:166-172, 1995
36. Anderson AJ, Cummings BJ, Cotman CW: Increased immunore activity of jun- and fos-related proteins in Alzheimer's disease: Association with pathology. Exp Neurol 125:286-295, 1994
37. Anderson AJ, Su JH, Cotman CW: DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 16:1710-1719, 1996
38. Allsopp TE, Wyatt A, Paterson HF, Davies AM: The protooncogen bcl-2 can selectively recue neurotrophic-factor dependent neurons from apoptosis. Cell 73:295-307, 1993
39. Martinou J, Duhois-Dauphin M, Staple J, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C: Overexpression of bcl-2 in transgenic mice protects neurons from naturally occuring death and experimental isehemia. Neuron 13:1017-1030, 1994
40. Paradis E, Douillard H, Koutroumanis M, Goodyer C, LeBlanc A: Amyloid β peptide of Alzheimer's disease downregulates bcl-2 and uppregulates Bax expression in human neurons. J Neurosci 16:7533-7539, 1996
41. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW: Apoptosis is induced by β-amyloid in cultured central nervous neurons. Proc Natl Acad Sci USA 90:7951-7755, 1993
42. Li Y-P, Bushnell AF, Lee C-M, Perlmutter LS, Wong SK-F: β-Amyloid induces apoptosis in human-derived neurotypic SH-SY 5Y cells. Brain Res 738:196-204, 1996
43. Jellinger KA: Diagnostic accuracy of Alzheimer's disease: A clinicopathological study. Acta Neuropathol 91:219-220, 1996
44. Kosunen O, Soininen H, Paljärvi L, Heinonen O, Talasniemi S, Rickkinen PJ Sr: Diagnostic accuracy of Alzheimer's disease: a neuropathological study. Acta Neuropathol 91:185-193, 1996